JPRN-UMIN000012546
Completed
未知
Autologous peripheral blood stem cell transplantation as consolidation for high risk diffuse large B-cell lymphoma:A phase II study - Up-front transplantation for high risk diffuse large B-cell lymphoma:A phase II study
ishiwaki Municipal Hospital0 sites18 target enrollmentJanuary 6, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diffuse Large B-Cell Lymphoma:IPI high risk group, CR1
- Sponsor
- ishiwaki Municipal Hospital
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Drug allergy used for conditioning regimen. 2\.Positive HBs antigen or seropositive to HIV.(Not exclude for seropositive to HCV) 3\.Uncontrolled infection. 4\.Patients inappropriate for transplantation with reasons other than above.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)JPRN-UMIN000026084agoya University Graduate School of Medicine10
Recruiting
Not Applicable
Autologous peripheral blood stem cell transplantation for elderly patients (65-74 years old) with multiple myeloma.multiple myelomaJPRN-UMIN000038905Tokyo-Kita Medical Center20
Completed
Phase 2
Autologous peripheral blood stem cell transplantation using MEAM regimen with HAART for refractory and relapsed HIV associated lymphoma: multicentered phase2 clinical trialRefractory and relapsed HIV associated lymphomaJPRN-UMIN000003159Research fund of Ministry Health, Labour and Welfare for a counter measure against AIDS, Okada group and Tanabe group18
Not yet recruiting
Not Applicable
Autologous Peripheral Blood Stem Cell Treatment for Myocardial Regeneration in Acute Myocardial InfarctioDiseases of the circulatory systemKCT0006114Seoul National University Hospital105
Completed
Not Applicable
autologous hematopoietic stem cell transplantation followed by reduced intensity allogeneic stem cell transplantation for relatively young patients with multiple myelomamultiple myelomaJPRN-UMIN000002533The university of Tokyo Hospital,department of hematology and oncology20